Bio-Techne Corp Common Stock Earnings Dividend

Bio-Techne Corp Common Stock’s revenue fell -1.51% since last year same period to $311.42Mn in the Q1 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 5.25% jump in its revenue since last 3-months.

Bio-Techne Corp Common Stock’s net profit jumped 126.04% since last year same period to $51.06Mn in the Q1 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 34.33% jump in its net profits since last 3-months.

Bio-Techne Corp Common Stock’s net profit margin jumped 129.5% since last year same period to 16.4% in the Q1 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 27.63% jump in its net profit margins since last 3-months.

Bio-Techne Corp Common Stock’s price-to-earnings ratio after this Q1 2026 earnings stands at 103.27.

Bio-Techne Corp Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.46 - a -13.21% fall from last quarter’s estimates.

Bio-Techne Corp Common Stock’s earning per share (EPS) estimates for the current year stand at 0.46.

Bio-Techne Corp Common Stock’s earning per share (EPS) fell -3.77% since last year same period to 0.51 in the Q2 2026. This indicates that the Bio-Techne Corp Common Stock has generated -3.77% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Bio-Techne Corp Common Stock declared 0.08 dividend per share during the earnings announcement for Q2 2026.